Aciphex
Product Images NDC 68151-3834

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Aciphex (NDC 68151-3834). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aciphex Is Available For Oral Administration As Delayed-release, Enteric-coated Tablets Containing 20 mg Of Rabeprazole Sodium. (Aciphex 01)

Chemical structure of the active ingredient in AcipHex, depicted as a detailed molecular diagram showing the arrangement of atoms and bonds in the compound.*

FDA Label Image

Mean Daytime Heartburn Scores Rab-usa-2 (Aciphex 02)

A line graph depicting mean heartburn scores over a study period of approximately 42 days, including pre-study and study days, for three groups: placebo, Rabeprazole 10 mg (RAB 10mg), and Rabeprazole 20 mg (RAB 20mg). The Y-axis shows heartburn scores from 0 (none) to 4 (very severe). The data indicate a decrease in heartburn scores after day 0 for both Rabeprazole doses compared to placebo.*

FDA Label Image

Mean Nighttime Heartburn Scores Rab-usa-2 (Aciphex 03)

A line graph showing mean heartburn scores over a 28-day study period for three groups: placebo, 10 mg AcipHex (rabeprazole), and 20 mg AcipHex (rabeprazole). The x-axis represents study days from -14 to 28, and the y-axis shows mean heartburn scores ranging from 0 (none) to 4 (very severe). The graph illustrates score trends before and after the treatment start day (day 0).*

FDA Label Image

Mean Daytime Heartburn Scores Rab-usa-3 (Aciphex 04)

A line graph comparing mean heartburn scores over 28 study days between two groups: placebo (n=58) and RAB 20 mg (n=59). The y-axis represents mean heartburn scores from 0 (none) to 4 (very severe), and the x-axis shows study days from -14 to 28. The graph shows a trend of decreasing heartburn scores, particularly for the RAB 20 mg group after day 0.*

FDA Label Image

Mean Nighttime Heartburn Scores Rab-usa-3 (Aciphex 05)

A line graph comparing mean heartburn scores over study days between two groups: placebo (n=58) and RAB 20mg (n=59). The x-axis represents study days from -14 to 28, and the y-axis shows mean heartburn scores ranging from 0 (none) to 4 (very severe). The graph illustrates symptom changes during the study period.*

FDA Label Image

Label Image (Lbl681513834)

Label for AcipHex 20 MG delayed-release tablet containing rabeprazole sodium. The label shows manufacturer as EISAI, lot number 005834, and expiration date 09/14. It includes a barcode and specifies prescription use only. Labeler is Carilion Materials Management with product NDC 68151-3834.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.